NMDP’s Amy Ronneberg Recognized as Most Admired CEO by Minneapolis/St. Paul Business Journal
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, announced today that the Minneapolis / St. Paul Business Journal named CEO Amy Ronneberg to its 2024 list of Most Admired CEOs, an honor designated annually to 10 chief executives in the Twin Cities.
- MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, announced today that the Minneapolis / St. Paul Business Journal named CEO Amy Ronneberg to its 2024 list of Most Admired CEOs, an honor designated annually to 10 chief executives in the Twin Cities.
- The Journal will celebrate these leaders’ organizational and business acumen as well as community and industry achievements at a ceremony in late September.
- “I’m humbled and honored to be recognized among this stellar class of 2024 honorees,” Ronneberg said.
- Ronneberg embodies NMDP’s vision to create a world where every patient can receive their life-saving cell therapy, impacting over 26,000 lives since becoming CEO.